13th Annual International Meeting of the Institute of Human Virology of the University of Maryland School of Medicine

By: Robert C. Gallo, MD Founder and Director, IHV

Download the Poster. (PDF)

Dear Colleagues and Friends,

Robert C. Gallo Founder and Director, IHV

Welcome to the 13th Annual Meeting of the Institute of Human Virology (IHV), scheduled for Sunday, October 30 - Wednesday, November 2, 2011. The Annual Meeting emphasizes the biology of HIV/AIDS, from the perspectives of basic science, clinical science and new treatments and prevention. This year, we begin with a satellite session focusing on HIV and associated malignancies in developing countries entitled, "Expanding Research Opportunities on the African Continent." Our regular includes New Agents for Treating Viral Diseases; Mechanisms for Vaccine Protection Against HIV; Evaluating Candidate HIV Vaccines; Interactions of Viruses and Host Cells; Immune Mechanisms Controlling Viral Diseases; Virally-associated Malignancies, and a variety of special lectures on important, emerging topics. We look forward to meeting colleagues, new and old.

For 2011, our meeting returns to the Marriott Waterfront Hotel located in the Harbor East community of Baltimore City. The University of Maryland Baltimore (UMB) Southern Management Corporation (SMC) Campus Center will be the site for our Poster Sessions during the meeting, and we invite all of our participants to see the UMB campus during evening poster sessions and receptions.

We are proud to honor Max Essex, PhD, the Mary Woodward Lasker Professor of Health Sciences and Chairman of the Harvard School of Public Health AIDS Initiative. Dr. Essex was among the first to link animal and human retroviruses with immunosuppressive diseases.

We are also proud to we present the IHV Lifetime Achievement Award for Public Service to Dr. Bernadine Healy. Dr. Healy was a physician, educator, health administrator and the first woman to head the National Institutes of Health (NIH). Known for her honest and courageous leadership and innovative policymaking, Dr. Healy was particularly effective in addressing medical policy and research programs pertaining to women's health.

Please join us In Baltimore for what promises to be an exciting few days of the most important developments in science.

Sincerely,

Robert C. Gallo, MD
Director and Professor
Institute of Human Virology